Related Experiment Videos
Platinum analogues in preclinical and clinical development
T C Hamilton1, P J O'Dwyer, R F Ozols
1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111.
Current Opinion in Oncology
|November 1, 1993
Summary
Researchers are developing new platinum-based chemotherapy drugs to improve cancer treatment. These platinum analogues aim to enhance antitumor activity and reduce side effects compared to cisplatin.
Area of Science:
- Oncology
- Medicinal Chemistry
Background:
- Cisplatin is a cornerstone chemotherapy drug for solid tumors.
- Its efficacy is limited by dose-limiting toxicities.
Purpose of the Study:
- To synthesize novel platinum analogues.
- To improve antitumor activity and reduce side effects of cisplatin.
Main Methods:
- Development of molecules with platinum as the central building block.
- Clinical and preclinical testing of platinum analogues.
Main Results:
- Multiple platinum analogues show promise.
- At least 10 molecules are in clinical development.
Conclusions:
- Platinum analogues represent a significant advancement in chemotherapy.
- Ongoing research aims to optimize cancer treatment strategies.